Literature DB >> 18771423

The disappearing act of factor VIII.

P J Lenting1, O D Christophe, P Guéguen.   

Abstract

Factor VIII (FVIII) is a plasma protein critical to the haemostatic system. This notion is illustrated by the severe bleeding disorder that is associated with its functional absence, known as haemophilia A. In addition, several epidemiological studies have revealed an association between the presence of elevated levels of FVIII and thrombotic complications. In view of its relation to thrombotic and haemorrhagic disorders, it is not surprising that FVIII has gained wide attention from the research community in the previous decades. This research has led to a better understanding of not only the structural, functional and physiological aspects of this intriguing protein, but also of the pathogenesis of haemostatic defects associated with FVIII. In the present review, focus will be on the interaction between FVIII and surface receptors that are able to capture FVIII. These interactions are of importance for FVIII, as they may affect both function and survival of FVIII.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18771423     DOI: 10.1111/j.1365-2516.2008.01864.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  13 in total

1.  Factor VIII and von Willebrand factor are ligands for the carbohydrate-receptor Siglec-5.

Authors:  Julie N Pegon; Mohamad Kurdi; Caterina Casari; Soline Odouard; Cécile V Denis; Olivier D Christophe; Peter J Lenting
Journal:  Haematologica       Date:  2012-06-24       Impact factor: 9.941

2.  Lectin binding assays for in-process monitoring of sialylation in protein production.

Authors:  Weiduan Xu; Jianmin Chen; Glenn Yamasaki; John E Murphy; Baisong Mei
Journal:  Mol Biotechnol       Date:  2010-07       Impact factor: 2.695

3.  Modification of an exposed loop in the C1 domain reduces immune responses to factor VIII in hemophilia A mice.

Authors:  Aleksandra Wroblewska; Simon D van Haren; Eszter Herczenik; Paul Kaijen; Aleksandra Ruminska; Sheng-Yu Jin; X Long Zheng; Maartje van den Biggelaar; Anja ten Brinke; Alexander B Meijer; Jan Voorberg
Journal:  Blood       Date:  2012-04-12       Impact factor: 22.113

4.  FVIII regulates the molecular profile of endothelial cells: functional impact on the blood barrier and macrophage behavior.

Authors:  Marie Cadé; Javier Muñoz-Garcia; Antoine Babuty; Louis Paré; Denis Cochonneau; Karim Fekir; Mathias Chatelais; Marie-Françoise Heymann; Anna Lokajczyk; Catherine Boisson-Vidal; Dominique Heymann
Journal:  Cell Mol Life Sci       Date:  2022-02-21       Impact factor: 9.261

5.  Effects of replacement of factor VIII amino acids Asp519 and Glu665 with Val on plasma survival and efficacy in vivo.

Authors:  Matthew P Kosloski; Krithika A Shetty; Hironao Wakabayashi; Philip J Fay; Sathy V Balu-Iyer
Journal:  AAPS J       Date:  2014-06-17       Impact factor: 4.009

6.  Recombinant factor VIII in the management of hemophilia A: current use and future promise.

Authors:  Jerry S Powell
Journal:  Ther Clin Risk Manag       Date:  2009-05-20       Impact factor: 2.423

7.  FcRn Rescues Recombinant Factor VIII Fc Fusion Protein from a VWF Independent FVIII Clearance Pathway in Mouse Hepatocytes.

Authors:  Arjan van der Flier; Zhan Liu; Siyuan Tan; Kai Chen; Douglas Drager; Tongyao Liu; Susannah Patarroyo-White; Haiyan Jiang; David R Light
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

8.  Phase I study of BAY 94-9027, a PEGylated B-domain-deleted recombinant factor VIII with an extended half-life, in subjects with hemophilia A.

Authors:  T E Coyle; M T Reding; J C Lin; L A Michaels; A Shah; J Powell
Journal:  J Thromb Haemost       Date:  2014-04       Impact factor: 5.824

9.  Quantitative correlation between transcriptional levels of ER chaperone, peroximal protein and FVIII productivity in human Hek-293 cell line.

Authors:  Evandra Strazza Rodrigues; Virgínia Picanço-Castro; Marta Regina Espanhol; Luiz Alberto Martins de Andrade; Patricia Vianna Bonini Palma; Simone Kashima; Aparecida Maria Fontes; Dimas Tadeu Covas
Journal:  Springerplus       Date:  2013-07-18

10.  Molecular determinants of the factor VIII/von Willebrand factor complex revealed by BIVV001 cryo-electron microscopy.

Authors:  James R Fuller; Kevin E Knockenhauer; Nina C Leksa; Robert T Peters; Joseph D Batchelor
Journal:  Blood       Date:  2021-05-27       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.